Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SAGE - Sage Therapeutics Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call Transcript

SAGE - Sage Therapeutics Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call Transcript

Sage Therapeutics Inc.
Sage Therapeutics, Inc. (SAGE) Q1 2022 Earnings Conference Call May 03, 2022 08:00 AM ET Company Participants Helen Rubinstein - Investor Relations Barry Greene - Chief Executive Officer Jim Doherty - Chief Development Officer Kimi Iguchi - Chief Financial Officer Chris Benecchi - Chief Commercial Officer Conference Call Participants Laura Chico - Wedbush Tiffany Sun - JPMorgan Ritu Baral - Cowen Yatin Suneja - Guggenheim Evan Hua - BMO Capital Markets Vamil Divan - Mizuho Neena Bitritto-Garg - Citi Sumant Kulkarni - Canaccord Lachlan Hanbury-Brown - William Blair Yasmeen Rahimi - Piper Sandler Presentation Operator Good morning. Welcome to Sage Therapeutics' First Quarter 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors [Technical Difficulty] This call is the property of Sage Therapeutics and recording reduction or transmission of this call without the expressed written consent of Sage

For further details see:

Sage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Sage Therapeutics Inc.
Stock Symbol: SAGE
Market: NASDAQ
Website: sagerx.com
Menu
SAGE SAGE Quote SAGE Short SAGE News SAGE Articles SAGE Message Board
Get SAGE Alerts

News, Short Squeeze, Breakout and More Instantly...